Fractyl Health, Inc. Common Stock

NASDAQ:GUTS

Biotechnology

Healthcare
$4.16 -0.81%

-$0.01 today

Market cap
$55.18M
Beta
2.34
P/E (TTM)
-0.6
EPS (TTM)
-$1.42
52W Low $0.38High $2.45

Volume 0.10M

Average 2.07M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$96.82M

FY 2025 · Annual

Net Income

-$140.95M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00120K93K0
Cost of Revenue0452K77K50K0
Gross Profit0(452K)43K43K0
Gross Margin——35.8%46.2%—
Research & Development26.44M34.35M38.04M70.47M74.54M
Selling, General & Admin10.49M14.58M0022.28M
Operating Expenses36.93M48.93M50.88M93.57M96.82M
Depreciation & Amortization676K452K286K677K1.13M
EBITDA(36.62M)(46M)(76.81M)(68.02M)(139.83M)
EBITDA Margin——-64004.2%-73136.6%—
Operating Income(36.93M)(49.39M)(50.84M)(93.53M)(96.82M)
Operating Margin——-42363.3%-100571.0%—
Interest Income0797K1.26M4.15M1.54M
Interest Expense1.44M0000
Other Income / Expenses(1.81M)2.93M(26.26M)24.84M(44.14M)
Income Before Tax(38.74M)(46.45M)(77.09M)(68.69M)(140.95M)
Pre-Tax Margin——-64242.5%-73864.5%—
Income Tax Expense00000
Net Income(38.74M)(46.45M)(77.09M)(68.69M)(140.95M)
Net Margin——-64242.5%-73864.5%—
EPS (Basic)(1.12)(1.34)(1.98)(1.62)(1.86)
EPS (Diluted)(1.12)(1.34)(1.98)(1.62)(1.86)
Weighted Avg Shares47.61M47.61M47.61M43.54M75.82M
Weighted Avg Shares (Diluted)47.61M47.61M47.61M43.54M75.82M

GUTS Earnings Waterfall · TTM

NASDAQ:GUTS · Revenue to Net Income

Key Ratios

EPS$-1.74
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.3
P/S Ratio0.0

Analysis

$0 of revenue converted into -$108.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.74, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 24, 2026
4Statement of changes in beneficial ownershipSep 16, 2026
8-KCurrent reportSep 11, 2026
DEF 14ADEF 14A filingAug 24, 2026
PRE 14APRE 14A filingAug 14, 2026

How much revenue does GUTS generate?

Fractyl Health, Inc. Common Stock (GUTS) reported $0.00 of revenue in fiscal 2025.

Is GUTS profitable?

Fractyl Health, Inc. Common Stock (GUTS) reported -$140.95M of net income.